Staffan Hildebrand returns to Australia, where he started his project of documenting the AIDS epidemic in 1988, and to Cambodia where he first arrived in 1998. He interviews some of the scientists and activists who he met back then and displays some footage from the archive.

XIX International AIDS Conference. Interview with Bernhard Schwartzlander from UNAIDS in Geneva. Schwartzländer is an expert on the statistics of HIV/AIDS. He talks about the HIV prevalence globally and the importance of early diagnosis and ARV treatment.

XVIII International AIDS Conference in Vienna. Interview with Richard Marlink, Professor at Harvard School of Public Health. He talks about a symposium on the history of HIV/AIDS and future strategies for ending AIDS, that was planned in Boston in 2011.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Swedish Dr Lars Olof Kallings who founded the International AIDS Society (IAS) in 1988 and who is now the United Nations Special Envoy for AIDS in Eastern Europe, reflects on the history of the AIDS movement.

XVII International AIDS Conference in Mexico City. Interview with Dr Mervyn Silverman from San Francisco, who has been active in the AIDS movement since the early 80's. Here he reflects on the leadership of UNAIDS Director Peter Piot.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.

Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.

Jonathan Mann, was a US medical doctor and influential within the World Health Organization (WHO). Here he talks about the global understanding of the disease between 1981 and 1988.